SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals
REGN 702.98-3.1%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: The Ox who wrote (2276)2/1/2018 10:54:10 PM
From: Miljenko Zuanic1 Recommendation

Recommended By
The Ox

  Read Replies (1) of 3559
 
Who care what Barclay's Geoff Meacham think or write in his report/note? Do your own DD, IF you have any brain, and argue here.

Maybe US AMD market is saturated (combine Laucentis-Eylea sale for last 2Q are flat), maybe Lucentis lost share against Avastin, while Eylea gain few points,...maybe DME/DR is long way to go, global sale can still further increase.... so his THESIS is at the best STUPID, as usual.
But, you have to have brain to figure it out!

Cheers, Miljenko
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News